2020 NLCRT Annual Meeting

Date: December 7-8, 2020

NLCRT Theme: Forging the New Frontier of Lung Cancer

Each year, the NLCRT membership, a nationwide coalition of over 140 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

We encourage NLCRT organizational members and non-members along with advocates, survivors and caregivers to register and attend the 4th Annual Meeting. Please feel free to share the registration link with colleagues and partners.

Not currently a member? Learn more about NLCRT membership.

Featured Speaker

Harry de Koning, MD, PhD

Dept. of Public Health, Erasmus MC University Medical Center Rotterdam, the Netherlands

Henricus J de Koning is currently serving as Deputy Head and Professor of Public Health & Screening Evaluation, Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Koning scientific contributions are in the areas of (1) designing, running and evaluating (often large-scale) multidisciplinary population-based randomized controlled screening trials to establish the efficacy of screening, (2) evaluating active (inter-)national screening programs and clinical tests to establish the effectiveness and (3) guiding public health policies on screening and primary prevention using predictions of favourable and unfavourable effects and the cost of interventions, based on micro-simulation modelling of the natural history of the disease, risk-prediction modelling and cost-effectiveness and cost-utility analyses. Our multidisciplinary and international research results in recommendations on whether or not to introduce screening, surveillance or other preventive interventions for specific diseases and on policy decisions to introduce it in specific ways, either at the population level or in (high risk) patients.

Agenda

9:50 am ET

Meeting Opens

10:00am ET – 10:45am ET

WELCOME TO THE NLCRT ANNUAL MEETING AND OPENING SESSION

Welcome and Opening Remarks
Ella Kazerooni, MD, MS, NLCRT Chair, University of Michigan

10:05am ET

Patient Story
TBD

10:15am ET

Keynote Address
Harry de Koning, MD, PhD, Erasmus Medical Center, Rotterdam, the Netherlands

10:45am ET – 1:00pm ET

SESSION TWO: APPRAISING LUNG CANCER ACROSS THE CARE CONTINUUM

10:45am ET

Lung Cancer Screening

Moderator: Peter Mazzone, MD, MPH, Cleveland Clinic

  • USPSTF Lung Cancer Screening Guidelines Update: Ella Kazerooni, MD, MS, University of Michigan
  • VA-PALS & GO2  Foundation for Lung Cancer Collaboration: Anita McGlothlin, GO2 Foundation for Lung Cancer
  • COVID-19: Screening and Lung Nodule Management Guidelines: Peter Mazzone, MD, MPH, Cleveland Clinic
  • First Million Screens in the American College of Radiology Lung Cancer Screening Registry: Gerard Silvestri, MD, MS, Medical University of South Carolina

11:15am ET

Break

11:30am ET

Tobacco Treatment

Moderator: Jamie Ostroff, PhD, Memorial Sloan Kettering Cancer Center

  • NCI Smoking Cessation at Lung Examination (SCALE) Collaboration: Stephanie Land, PhD, National Cancer Institute
  • NCI Cancer Center Cessation Initiative (C3I): Graham Warren, MD, PhD, Medical University of South Carolina
  • Surgeon General Report on Smoking Cessation: Brenna VanFrank, MD, MSPH, Centers for Disease Control and Prevention

Surgical, Radiation and Medical Oncology

Moderator: Bruce Johnson, MD, Dana-Farber Cancer Institute

  • Enforcing the Need for State-of-the-Art Surgical Interventions: Brendon Stiles, MD, Weill Cornell Medicine
  • Stereotactic Radiotherapy Advancements: Anurag Singh, MD, Roswell Park Comprehensive Cancer Center
  • Targeted Therapy Advancements: Raymond Osarogiagbon, MBBS, Baptist Cancer Center, Memphis
  • COVID-19 in Patients with Lung Cancer: Gregory Riely, MD, PhD, Memorial Sloan Kettering Cancer Center

Disparities, Survivorship, Policy and Practice in Lung Cancer Care

Moderator: M. Patricia Rivera, MD, University North Carolina at Chapel Hill

  • Addressing Disparities in Lung Cancer Screening and Access: Louise Henderson, PhD, University of North Carolina at Chapel Hill
  • Fitness, Depression & Survivorship + COVID-19 in Lung Cancer Care: Brett Bade, MD, Yale University
  • HEDIS Measure & Telehealth Related to Screening and Access:  Ruth Carlos, MD, MS, University of Michigan
  • Improving Access to Biomarker Testing: Devon Adams, RN, MPH, ACS CAN

1:00pm ET

Break

1:15pm ET – 2:15pm ET

SESSION THREE: POSTER SESSION

Moderator: Jill Feldman, EGFR Resisters

2:15pm

Break

2:30pm ET – 4:30pm ET

SESSION FOUR: TASK GROUP SHOWCASES

Co-Moderators:
Joelle Fathi, DNP, ARNP, University of Washington
Jamie Studts, PhD, University of Colorado

2:30pm ET

Provider Engagement and Outreach Task Group
Chair: Thomas Houston, MD, American Academy of Family Physicians
Vice-Chair: Jan Eberth, PhD, University of South Carolina

3:00pm ET

Shared Decision-Making Task Group
Chair: Robert Volk, PhD, MD Anderson Cancer Center
Vice Chair: Peter Mazzone, MD,MPH Cleveland Clinic

3:30pm ET

Lung Cancer Screening Implementation Strategies Task Group
Chair: Charles White, MD, University of Maryland
Vice Chair: Carey Thomson, MD,MPH  Mt. Auburn/Beth Israel Lahey Health

4:00pm ET

Tobacco Treatment in the Context of Lung Cancer Screening Task Group
Chair: Jamie Ostroff, PhD, Memorial Sloan Kettering Cancer Center
Vice Chair: Joelle Fathi,DNP, ARNP, University of Washington

4:30pm ET

CLOSING REMARKS AND END OF DAY 1

9:50am ET

MEETING OPENS

10:00am ET – 10:35am ET

WELCOME TO DAY 2 OF THE NLCRT ANNUAL MEETING

Welcome and Opening Remarks
Douglas Wood, MD, NLCRT Vice Chair, University of Washington

10:05am ET

Patient Story

TBD

10:15 am ET

National Estimates of Access to and Utilization of Lung Cancer Screening

  • Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States: Liora Sahar, PhD, GISP, American Cancer Society
  • State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States: Stacey Fedewa, PhD, MPH,  American Cancer Society

10:35am ET – 1:00 pm ET

SESSION SIX: NLCRT PRIORITY INITIATIVES AND SPECIAL PROJECTS

10:35am ET

NLCRT Highlight: Summits & Initiatives
Moderator: Gerard Silvestri, MD, MS, Medical University of South Carolina

  • NLCRT Strategic Plan: Robert Smith, PhD, NLCRT PI, American Cancer Society
  • Eliminating Lung Cancer Stigma: A National Initiative
    • Summit and Initiative Overview – Lisa Carter-Harris, PhD, APRN, ANP-C, Memorial Sloan Kettering Cancer Center
    • Advocate Perspective – Dusty Donaldson, Dusty Joy Foundation, LungCAN
    • Stigma Initiative Strategic Plan – Jamie Studts, PhD, University of Colorado
  • Optimizing Lung Cancer Biomarkers in Practice: A National Initiative
    • Summit and Initiative Overview – M. Patricia Rivera, MD, University of North Carolina at Chapel Hill
    • Stakeholder Confessions on Barriers to Comprehensive Biomarker Testing – Farhood Farjah, MD, MPH, University of Washington
    • Advocate Perspective– Gina Hollenbeck, RN, BSN, ALK Positive
    • Biomarker Initiative Strategic Plan – Bruce Johnson, MD, Dana-Farber Cancer Institute

12:00pm ET

NLCRT Highlight: Priority Projects
Moderator: Carey Thomson, MD, MPH, Mt. Auburn/Beth Israel Lahey Health

  • State Lung Cancer Coalition-Building Guide: Jessica Olson, PhD, Medical College of Wisconsin
  • High Quality Lung Cancer Screening and Nodule Surveillance Programs – Modeling for Implementation and Programmatic Expansion: Carey Thomson, MD, MPH, Mt. Auburn/Beth Israel Lahey Health
  • Partnership with American Academy of Family Physicians – Shared Decision-Making Tools: Robert Volk, PhD, MD Anderson Cancer Center
  • American Cancer Society Regional Cancer Control Update: Letitia Thompson, MPA, American Cancer Society

1:00pm ET

BREAK

1:15pm – 2:15pm ET

SESSION SEVEN: ADVOCACY/HEALTH PLAN/INDUSTRY PANEL

Moderator: Robert Smith, PhD, American Cancer Society

2:15pm ET

BREAK

2:30pm – 4:30pm ET

SESSION EIGHT: TASK GROUP SHOWCASE

Co-Moderators:
Jane Kim, MD, MPH, Department of Veterans Affairs
Douglas Wood, MD, University of Washington

2:30pm ET

Lung Cancer in Women Task Group
Chair: Leah Backhus, MD, MPH, Stanford University
Vice Chair: M. Patricia Rivera, MD, University of North Carolina at Chapel Hill

3:00pm ET

State-Based Initiatives
Chair: Jessica Olson, PhD, Medical College of Wisconsin
Vice Chair: Timothy Mullett, MD, MBA, University of Kentucky

3:30pm ET

Advanced Imaging Task Group
Chair: Daniel Sullivan, MD, Duke University
Vice Chair: Michael McNitt-Gray, PhD, University of California, Los Angeles

4:00pm ET

Policy Action Task Group
Chair: Ruth Carlos, MD,MS, University of Michigan

4:30pm ET

CLOSING REMARKS AND END OF ANNUAL MEETING